Use of Commercial Genomic Testing for Prostate Cancer ‘Highly Variable’ in the United States
Investigators evaluated a large sample of commercially insured patients with prostate cancer to assess use of tissue-based gene expression testing.
Susan Jenks
Susan Jenks is a longtime medical journalist who has written for the Arizona Republic and the press offices of the National Cancer Institute and Stanford University Medical Center. Most recently, she helped shape a medical section for a Gannett paper.
